| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/12/1997 | CA2183020A1 Activated immunoglobulin |
| 02/12/1997 | CA2183012A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/11/1997 | US5602243 For amplification of a deleted in colorectal cancer gene by polymerase chain reaction |
| 02/11/1997 | US5602234 Stable antibody solution and method for preparing same |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602019 Genetic engineering |
| 02/11/1997 | US5602015 Autoantibodies which enhance the rate of a chemical reaction |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602008 Genetic engineering |
| 02/11/1997 | US5602005 Antigen remains associated with primate sperm after acrosome reaction |
| 02/11/1997 | US5601993 Detecting colon cancer and latent colon cancer by measuring concentrations of primary and secondary bile acids in feces by elisa, calculating ratio |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601826 A linear tetanus-toxin-specific epitope |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601823 Avian antitoxins to clostridium difficle toxin A |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601819 Bispecific monoclonal antibody having common fc portion, first fab portion specific for cd3, second fab portion specific for interleukin-2 receptor, cd28, cd45 or cdtfr |
| 02/11/1997 | US5601815 Coadministering to the mammal an effective dose of each of interleukin-4 and 10 |
| 02/06/1997 | WO1997004317A1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
| 02/06/1997 | WO1997004315A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004133A1 Analysis of alpha integrins for the diagnosis of diabetic nephropathy |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004080A1 Novel protein and monoclonal antibody specific thereto |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003995A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003691A1 Methods of treatment of neurological diseases by interferon antagonists |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1996041608A3 Pyrularia thionin containing immunotoxins and immunotoxin-like conjugates |
| 02/06/1997 | WO1996040926A3 Detection of cryptosporidium parvum |
| 02/06/1997 | DE19540515C1 Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten Tumor therapy by adoptive transfer CD44v-specific cytotoxic T lymphocytes |
| 02/06/1997 | DE19528029A1 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use |
| 02/06/1997 | CA2227882A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | CA2227592A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | CA2227537A1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2226911A1 Methods of treatment of neurological diseases by interferon antagonists |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2223914A1 Compositions and methods for catalyzing hydrolysis of hiv gp120 |
| 02/05/1997 | EP0757099A2 CTLA4 mutant molecules and uses thereof |
| 02/05/1997 | EP0756871A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 02/05/1997 | EP0756708A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation |
| 02/05/1997 | EP0756628A1 Morphogenic protein-specific cell surface receptors and uses therefor |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756604A1 Melanoma antigens |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0756488A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
| 02/05/1997 | CN1142189A Platelet-special chimeric immunoglobulin and methods of use thereof |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/04/1997 | US5599918 Nucleic acids encoding trophinin and trophinin-assisting proteins |
| 02/04/1997 | US5599912 Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances |
| 02/04/1997 | US5599909 Process for reactivating purified membrane proteins |
| 02/04/1997 | US5599908 Method for constructing a hybrid reagent for delivering a bioactive molecule to a cellular target |
| 02/04/1997 | US5599905 Interleukin-4 receptors |
| 02/04/1997 | US5599903 Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/04/1997 | US5599844 Administering agent to elevate level of transforming growth factor beta |
| 02/04/1997 | US5599790 Fibrinogen γ chain polypeptide and compositions thereof |
| 02/04/1997 | US5599719 Method for isolating biomolecules from a biological sample with linear polymers |
| 02/04/1997 | US5599708 Stimulate formation of osteoclast bone cells; treatment of bone marrow disorders |
| 02/04/1997 | US5599707 Human prohibitin DNA |
| 02/04/1997 | US5599693 Culture product |
| 02/04/1997 | US5599692 Antigenic polypeptides of Taenia ovis |
| 02/04/1997 | US5599681 Activation-state-specific phosphoprotein immunodetection |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 02/04/1997 | US5599677 Immunoassays for prostate specific antigen |
| 02/04/1997 | US5599676 Method for isolating a novel receptor for α4 integrins |
| 02/04/1997 | US5599669 Cytokine-induced marker for inflammatory response |
| 02/04/1997 | US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage |
| 02/04/1997 | US5599539 Administering avian antitoxin |
| 02/04/1997 | US5599538 Catalyzing the hydrolysis of the peptide bonde between amino acid residues, e.g. the vasoactive intestinal peptide; anticarcinogenic agents; viricides; bactericides; protozoa; medical diagnosis |
| 01/30/1997 | WO1997003360A1 HELICOBACTER VACCINE ANTIGEN RECOGNIZED BY A PROTECTIVE MONOCLONAL ANTIBODY (IgG 50) |
| 01/30/1997 | WO1997003203A2 Generation of immune responses to prostate-specific antigen (psa) |
| 01/30/1997 | WO1997003198A2 Nucleotide and amino acid sequence and uses thereof |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002839A1 Viral suppression, treatment and prevention of viral infections |
| 01/30/1997 | WO1996039513A3 Ebnerin cloning of a secreted von ebner's gland protein |
| 01/30/1997 | DE19527552A1 Transketolase-verwandtes-Protein Transketolase-related protein |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/29/1997 | EP0756006A2 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755684A1 Vaccine conjugate |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755518A1 Method for the immuno-assay of antithrombin iii activated by a glycosaminoglycan, corresponding monoclonal antibodies and method for producing them |
| 01/29/1997 | EP0755517A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 01/29/1997 | EP0755451A1 Materials and methods for management of hyperacute rejection in human xenotransplantation |